Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study

Abstract Background With the development of minimally invasive surgery technology, patients with bladder cancer are increasingly receiving laparoscopic radical cystectomy (LRC) or robotic-assisted radical cystectomy (RARC) treatment. The main purpose of this study was to compare the long-term outcom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuchen Bai, Shuai Wang, Wei Zheng, EnHui Li, Jing Quan, Fei Wei, Qi Zhang, XiaoLong Qi, DaHong Zhang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/18a599ed1d05486f95ff1d7782a203dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:18a599ed1d05486f95ff1d7782a203dd
record_format dspace
spelling oai:doaj.org-article:18a599ed1d05486f95ff1d7782a203dd2021-11-07T12:09:57ZClinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study10.1186/s12893-021-01382-11471-2482https://doaj.org/article/18a599ed1d05486f95ff1d7782a203dd2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12893-021-01382-1https://doaj.org/toc/1471-2482Abstract Background With the development of minimally invasive surgery technology, patients with bladder cancer are increasingly receiving laparoscopic radical cystectomy (LRC) or robotic-assisted radical cystectomy (RARC) treatment. The main purpose of this study was to compare the long-term outcomes of bladder cancer patients treated with LRC versus RARC. Methods A retrospective study to identify patients with clinical stage Ta/T1/Tis to T3 bladder cancer who underwent RARC or LRC has been performed. The perioperative outcome, recurrence, and overall survival (OS) of the two surgical methods were compared. Results 218 patients were identified from March 2010 to December 2019 in our department, which including 82 (38%) patients who received LRC and 136 (62%) patients who received RARC. There was no significant difference between the two groups in terms of lymph node collection, lymph node positive rate, resection margin positive rate, and postoperative pathological staging. Compared with the LRC group, patients in the RARC group had a median estimated blood loss (180 vs. 250 ml; P = 0.02) and reduced complications at 90 days postoperatively (30.8% vs. 46.3%; P = 0.01). Recurrence, all-cause death, and cancer-specific death occurred in 77 (35%), 55 (25%), and 39 (18%) patients, respectively. The 5-year OS rate was 54.63% and 54.65% in the RARC and LRC group (P > 0.05). The 5-year cancer-specific survival (CSS) rate was 73.32% and 61.55% in RARC and LRC group (P > 0.05). There was no significant difference in OS [hazard ratio (HR) 1.083, 95% confidence interval (CI) 0.626–1.874; P = 0.78], and CSS (HR 0.789, 95%CI 0.411–1.515; P = 0.61) between two groups. Conclusions Both RARC and LRC were safe and effective with a similar long-term clinical outcomes. Moreover, RARC had significantly lower median estimated blood loss and reduced postoperative complications.Yuchen BaiShuai WangWei ZhengEnHui LiJing QuanFei WeiQi ZhangXiaoLong QiDaHong ZhangBMCarticleBladder cancerOutcomeLaparoscopic radical cystectomyRobot-assisted radical cystectomySurgeryRD1-811ENBMC Surgery, Vol 21, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Bladder cancer
Outcome
Laparoscopic radical cystectomy
Robot-assisted radical cystectomy
Surgery
RD1-811
spellingShingle Bladder cancer
Outcome
Laparoscopic radical cystectomy
Robot-assisted radical cystectomy
Surgery
RD1-811
Yuchen Bai
Shuai Wang
Wei Zheng
EnHui Li
Jing Quan
Fei Wei
Qi Zhang
XiaoLong Qi
DaHong Zhang
Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
description Abstract Background With the development of minimally invasive surgery technology, patients with bladder cancer are increasingly receiving laparoscopic radical cystectomy (LRC) or robotic-assisted radical cystectomy (RARC) treatment. The main purpose of this study was to compare the long-term outcomes of bladder cancer patients treated with LRC versus RARC. Methods A retrospective study to identify patients with clinical stage Ta/T1/Tis to T3 bladder cancer who underwent RARC or LRC has been performed. The perioperative outcome, recurrence, and overall survival (OS) of the two surgical methods were compared. Results 218 patients were identified from March 2010 to December 2019 in our department, which including 82 (38%) patients who received LRC and 136 (62%) patients who received RARC. There was no significant difference between the two groups in terms of lymph node collection, lymph node positive rate, resection margin positive rate, and postoperative pathological staging. Compared with the LRC group, patients in the RARC group had a median estimated blood loss (180 vs. 250 ml; P = 0.02) and reduced complications at 90 days postoperatively (30.8% vs. 46.3%; P = 0.01). Recurrence, all-cause death, and cancer-specific death occurred in 77 (35%), 55 (25%), and 39 (18%) patients, respectively. The 5-year OS rate was 54.63% and 54.65% in the RARC and LRC group (P > 0.05). The 5-year cancer-specific survival (CSS) rate was 73.32% and 61.55% in RARC and LRC group (P > 0.05). There was no significant difference in OS [hazard ratio (HR) 1.083, 95% confidence interval (CI) 0.626–1.874; P = 0.78], and CSS (HR 0.789, 95%CI 0.411–1.515; P = 0.61) between two groups. Conclusions Both RARC and LRC were safe and effective with a similar long-term clinical outcomes. Moreover, RARC had significantly lower median estimated blood loss and reduced postoperative complications.
format article
author Yuchen Bai
Shuai Wang
Wei Zheng
EnHui Li
Jing Quan
Fei Wei
Qi Zhang
XiaoLong Qi
DaHong Zhang
author_facet Yuchen Bai
Shuai Wang
Wei Zheng
EnHui Li
Jing Quan
Fei Wei
Qi Zhang
XiaoLong Qi
DaHong Zhang
author_sort Yuchen Bai
title Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
title_short Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
title_full Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
title_fullStr Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
title_full_unstemmed Clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
title_sort clinical outcome of laparoscopic versus robot-assisted radical cystectomy for patients with bladder cancer: a retrospective study
publisher BMC
publishDate 2021
url https://doaj.org/article/18a599ed1d05486f95ff1d7782a203dd
work_keys_str_mv AT yuchenbai clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT shuaiwang clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT weizheng clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT enhuili clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT jingquan clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT feiwei clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT qizhang clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT xiaolongqi clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
AT dahongzhang clinicaloutcomeoflaparoscopicversusrobotassistedradicalcystectomyforpatientswithbladdercanceraretrospectivestudy
_version_ 1718443472252305408